Somero Enterprises, Inc. (AIM:SOM)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 123.77M |
| Revenue (ttm) | 87.19M |
| Net Income (ttm) | 14.86M |
| Shares Out | 54.52M |
| EPS (ttm) | 0.26 |
| PE Ratio | 8.61 |
| Forward PE | 14.49 |
| Dividend | 0.16 (6.87%) |
| Ex-Dividend Date | Apr 10, 2025 |
| Volume | 39,801 |
| Average Volume | 182,804 |
| Open | 226.00 |
| Previous Close | 226.00 |
| Day's Range | 223.50 - 230.00 |
| 52-Week Range | 173.00 - 340.00 |
| Beta | 0.64 |
| RSI | 52.47 |
| Earnings Date | Sep 9, 2025 |
About Ligand Pharmaceuticals
Somero Enterprises, Inc. designs, assembles, remanufactures, sells, and distributes concrete leveling, contouring, and placing equipment. The company offers ride-on, boom, and stationary laser screeds; concrete placement products; lightweight screeds; compact boom screeds; and materials placement equipment comprising broom/curing machine, line-pulling and placing system, and topping spreaders. It also provides related parts and accessories, software packages, and training services. In addition, the company’s equipment is used to place and scree... [Read more]
Financial Performance
In 2024, Somero Enterprises's revenue was $109.15 million, a decrease of -9.57% compared to the previous year's $120.70 million. Earnings were $18.60 million, a decrease of -33.50%.
Financial StatementsNews
AIM Market Roundup: Caledonian, Getech, Rome Resources
Caledonian, Getech, Rome Resources are today's top risers, while RWS, Somero Enterprises take the biggest fall on London's AIM market